Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.15 USD | +0.90% | -0.45% | +28.75% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.75% | 2.29B | |
+10.02% | 3,075B | |
+8.25% | 85.03B | |
+4.44% | 77.41B | |
-14.19% | 53.89B | |
-23.14% | 47.59B | |
+21.96% | 46.63B | |
+21.64% | 42.81B | |
+59.16% | 37.02B | |
-10.56% | 24.56B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Earnings Flash (CLBT) CELLEBRITE Reports Q3 Revenue $65.9M, vs. Street Est of $59.3M